4.5 Article

Refining diagnosis of Parkinson's disease with deep learning-based interpretation of dopamine transporter imaging

期刊

NEUROIMAGE-CLINICAL
卷 16, 期 -, 页码 586-594

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.nicl.2017.09.010

关键词

Parkinson's disease; FP-CIT; Deep learning; Deep neural network; SWEDD

资金

  1. Michael J. Fox Foundation for Parkinson's Research
  2. Abbvie
  3. Avid Radiopharmaceuticals
  4. Biogen Idec
  5. Bristol-Myers Squibb
  6. Covance
  7. Eli Lilly Co
  8. F Hoff man-La Roche
  9. GE Healthcare
  10. Genentech
  11. GlaxoSmithKline
  12. Lundbeck
  13. Merck
  14. MesoScale
  15. Piramal
  16. Pfizer
  17. UCB
  18. Korea Health Technology R & D Project through Korea Health Industry Development Institute (KHIDI)
  19. Ministry of Health & Welfare, Republic of Korea [HI14C0466, HI14C3344, HI14C1277]
  20. Technology Innovation Program [10052749]
  21. National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2017M3C7A1048079]
  22. Korea Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries, Republic of Korea [311011-05-3-SB020]
  23. Korea Healthcare Technology R & D Project - Ministry of Health & Welfare, Republic of Korea [HI11C21100200]
  24. Technology Innovation Program - Ministry of Trade, Industry & Energy (MI, Korea) [10050154]
  25. Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [2015M3C7A1028926]
  26. National Research Foundation of Korea - Ministry of Science and ICT [NRF-2017M3C7A1047392]

向作者/读者索取更多资源

Dopaminergic degeneration is a pathologic hallmark of Parkinson's disease (PD), which can be assessed by dopamine transporter imaging such as FP-CIT SPECT. Until now, imaging has been routinely interpreted by human though it can show interobserver variability and result in inconsistent diagnosis. In this study, we developed a deep learning-based FP-CIT SPECT interpretation system to refine the imaging diagnosis of Parkinson's disease. This system trained by SPECT images of PD patients and normal controls shows high classification accuracy comparable with the experts' evaluation referring quantification results. Its high accuracy was validated in an independent cohort composed of patients with PD and nonparkinsonian tremor. In addition, we showed that some patients clinically diagnosed as PD who have scans without evidence of dopaminergic deficit (SWEDD), an atypical subgroup of PD, could be reclassified by our automated system. Our results suggested that the deep learning-based model could accurately interpret FP-CIT SPECT and overcome variability of human evaluation. It could help imaging diagnosis of patients with uncertain Parkinsonism and provide objective patient group classification, particularly for SWEDD, in further clinical studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据